| human | Q5 |
| P6178 | Dimensions author ID | 01105071425.30 |
| P856 | official website | http://www.gla.ac.uk/researchinstitutes/cancersciences/staff/kevinryan/ |
| P496 | ORCID iD | 0000-0002-1059-9681 |
| P10861 | Springer Nature person ID | 01105071425.30 |
| P69 | educated at | University of Liverpool | Q499510 |
| Beatson Institute for Cancer Research | Q25188472 | ||
| P108 | employer | University of Glasgow | Q192775 |
| University of Liverpool | Q499510 | ||
| P734 | family name | Ryan | Q5263823 |
| Ryan | Q5263823 | ||
| Ryan | Q5263823 | ||
| P735 | given name | Kevin | Q605834 |
| Kevin | Q605834 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q35664079 | A p53-derived apoptotic peptide derepresses p73 to cause tumor regression in vivo. |
| Q33694155 | Activation of p73 and induction of Noxa by DNA damage requires NF-kappa B. |
| Q24339433 | Analysis of DRAM-related proteins reveals evolutionarily conserved and divergent roles in the control of autophagy |
| Q38344632 | Analysis of E-box DNA binding during myeloid differentiation reveals complexes that contain Mad but not Max. |
| Q41813930 | Analysis of macroautophagy by immunohistochemistry |
| Q39583449 | Androgens modulate autophagy and cell death via regulation of the endoplasmic reticulum chaperone glucose-regulated protein 78/BiP in prostate cancer cells |
| Q37967998 | Autophagy and cancer |
| Q53269829 | Autophagy and cancer--issues we need to digest. |
| Q57247950 | Autophagy chews Fap to promote apoptosis |
| Q27000191 | Autophagy in malignant transformation and cancer progression |
| Q38115087 | Autophagy in tumour cell death |
| Q56609460 | Autophagy, Inflammation, and Metabolism (AIM) Center of Biomedical Research Excellence: supporting the next generation of autophagy researchers and fostering international collaborations |
| Q98193823 | Autophagy, the innate immune response and cancer |
| Q37676660 | Autophagy: an adaptable modifier of tumourigenesis |
| Q45037005 | Cancer: Viruses' backup plan |
| Q57248011 | Cell cycle arrest and DNA endoreduplication following p21Waf1/Cip1 expression |
| Q38345040 | Cell-cycle progression is not essential for c-Myc to block differentiation |
| Q33774492 | Characterization of structural p53 mutants which show selective defects in apoptosis but not cell cycle arrest |
| Q38313722 | DNA-binding independent cell death from a minimal proapoptotic region of E2F-1. |
| Q34000900 | DRAM links autophagy to p53 and programmed cell death |
| Q29616308 | DRAM, a p53-induced modulator of autophagy, is critical for apoptosis |
| Q39443251 | DRAM-1 encodes multiple isoforms that regulate autophagy |
| Q40991336 | DRAM-3 modulates autophagy and promotes cell survival in the absence of glucose |
| Q28508710 | Differentiating embryonal stem cells are a rich source of haemopoietic gene products and suggest erythroid preconditioning of primitive haemopoietic stem cells |
| Q39296611 | Does androgen-ablation therapy (AAT) associated autophagy have a pro-survival effect in LNCaP human prostate cancer cells? |
| Q38310909 | E2F1 drives chemotherapeutic drug resistance via ABCG2. |
| Q48239259 | Emerging roles of transcriptional programs in autophagy regulation |
| Q37641677 | Evidence for the interplay between JNK and p53-DRAM signalling pathways in the regulation of autophagy |
| Q39163275 | Extracellular adenosine sensing-a metabolic cell death priming mechanism downstream of p53. |
| Q41924376 | Glucose-starved cells do not engage in prosurvival autophagy |
| Q57246314 | Growth factor signaling permits hypoxia-induced autophagy by a HIF1α-dependent, BNIP3/3L-independent transcriptional program in human cancer cells |
| Q21996341 | Guidelines for the use and interpretation of assays for monitoring autophagy |
| Q22676705 | Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) |
| Q23757358 | Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes |
| Q57248008 | Hemizygosity of the MAX Gene Locus in HL60 Cells |
| Q39844165 | Hypoxia-selective macroautophagy and cell survival signaled by autocrine PDGFR activity |
| Q57247993 | Hzf and hCAS/CSE1L: making the right choice in p53-mediated tumour suppression |
| Q37680934 | Immunohistochemical detection of cytoplasmic LC3 puncta in human cancer specimens |
| Q41099375 | Induction of DNA synthesis and apoptosis are separable functions of E2F-1. |
| Q43619366 | Inhibition of HIF-1- and wild-type p53-stimulated transcription by codon Arg175 p53 mutants with selective loss of functions |
| Q39349314 | Inhibition of autophagy impairs tumor cell invasion in an organotypic model |
| Q35516643 | Involvement of RNA Polymerase III in Immune Responses. |
| Q35550235 | Life and death decisions by E2F-1. |
| Q35031397 | Loss of autophagy causes a synthetic lethal deficiency in DNA repair. |
| Q47255105 | Loss of nuclear factor-kappaB is tumor promoting but does not substitute for loss of p53. |
| Q27026045 | Lysosomal proteins in cell death and autophagy |
| Q28118946 | MDM2 promotes SUMO-2/3 modification of p53 to modulate transcriptional activity |
| Q38334174 | Mechanistic and predictive profiling of 5-Fluorouracil resistance in human cancer cells. |
| Q38735356 | Molecular definitions of autophagy and related processes. |
| Q47843948 | Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. |
| Q34062481 | Myc oncogenes: the enigmatic family |
| Q37981834 | New frontiers in promoting tumour cell death: targeting apoptosis, necroptosis and autophagy |
| Q41462289 | Oncogene-induced sensitization to chemotherapy-induced death requires induction as well as deregulation of E2F1. |
| Q39870608 | PUMA- and Bax-induced autophagy contributes to apoptosis |
| Q24631299 | Phosphorylation of Puma modulates its apoptotic function by regulating protein stability |
| Q57248001 | Pinning a change on p53 |
| Q34245385 | Regulation and function of the p53 tumor suppressor protein |
| Q39155203 | Retrograde signaling from autophagy modulates stress responses. |
| Q57248006 | Role of NF-κB in p53-mediated programmed cell death |
| Q38144288 | Role of autophagy in cancer prevention, development and therapy |
| Q36609038 | Senescence sensitivity of breast cancer cells is defined by positive feedback loop between CIP2A and E2F1. |
| Q35976600 | Splicing DNA-damage responses to tumour cell death. |
| Q28592817 | TSC-22D1 isoforms have opposing roles in mammary epithelial cell survival |
| Q36919798 | Targeting the p53 family for cancer therapy: 'big brother' joins the fight. |
| Q33889383 | The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. |
| Q39496691 | The cyclin-dependent kinase PITSLRE/CDK11 is required for successful autophagy |
| Q37840892 | The multiple roles of autophagy in cancer |
| Q37642093 | The role of autophagy in tumour development and cancer therapy. |
| Q47768840 | Transcriptional regulation of autophagy and lysosomal function by bromodomain protein BRD4. |
| Q24316301 | Tumor antigen LRRC15 impedes adenoviral infection: implications for virus-based cancer therapy |
| Q39422081 | Tumor regression following intravenous administration of a tumor-targeted p73 gene delivery system |
| Q41617373 | Ubiquitination and proteasomal degradation of ATG12 regulates its proapoptotic activity |
| Q38929715 | Using enhanced-mitophagy to measure autophagic flux. |
| Q39808307 | c-Jun NH2-terminal kinase activation is essential for DRAM-dependent induction of autophagy and apoptosis in 2-methoxyestradiol-treated Ewing sarcoma cells |
| Q37204552 | iASPP inhibition: increased options in targeting the p53 family for cancer therapy. |
| Q34911119 | p53 activates ICAM-1 (CD54) expression in an NF-kappaB-independent manner |
| Q37812885 | p53 and autophagy in cancer: Guardian of the genome meets guardian of the proteome |
| Q29617084 | p53 and metabolism |
| Q57247984 | p53 and senescence: A little goes a long way |
| Q39634575 | p53 and senescence: a little goes a long way. |
| Q57247977 | p53 and tumor surveillance: Killer finds way to recruit assassins |
| Q39048945 | p53 status determines the role of autophagy in pancreatic tumour development |
| Q39738650 | p53-mediated induction of Noxa and p53AIP1 requires NFkappaB. |
| Q39631491 | p53-mediated transcriptional regulation and activation of the actin cytoskeleton regulatory RhoC to LIMK2 signaling pathway promotes cell survival |
| Q38579148 | p73 engages A2B receptor signalling to prime cancer cells to chemotherapy-induced death |
| Q40170381 | p73 regulates DRAM-independent autophagy that does not contribute to programmed cell death |
Search more.